Improved sleep in military personnel is associated with changes in the expression of inflammatory genes and improvement in depression symptoms

Frontiers in Psychiatry

Volumn 6, Issue APR, 2015, Pages

  Livingston, Whitney S ^a   Rusch, Heather L ^a   Nersesian, Paula V ^a,b   Baxter, Tristin ^c   Mysliwiec, Vincent ^c   Gill, Jessica M ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF NURSING   (United States)

^c MADIGAN ARMY MEDICAL CENTER   (United States)

Author keywords

Depression; Gene expression; Inflammation; Insomnia; Military personnel

Indexed keywords

CATENIN; CYTOCHROME P450 1B1; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; POLYKETIDE SYNTHASE; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR NFATC2; UBIQUITIN; UNCLASSIFIED DRUG;

ARTICLE; DEPRESSION; DISEASE SEVERITY; FEMALE; GENE EXPRESSION PROFILING; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; POSTTRAUMATIC STRESS DISORDER; PROTEIN EXPRESSION; SLEEP DISORDERED BREATHING; SLEEP QUALITY; SOLDIER; TRAUMATIC BRAIN INJURY;

EID: 84930627575     PISSN: None     EISSN: 16640640     Source Type: Journal    
DOI: 10.3389/fpsyt.2015.00059     Document Type: Article

References (60)

1. Seelig AD, Jacobson IG, Smith B, Hooper TI, Boyko EJ, Gackstetter GD, et al. Sleep patterns before, during, and after deployment to Iraq and Afghanistan. Sleep (2010) 33(12):1615-22.
2. McLay RN, Klam WP, Volkert SL. Insomnia is the most commonly reported symptom and predicts other symptoms of post-traumatic stress disorder in U.S. service members returning from military deployments. Mil Med (2010) 175(10):759-62. doi: 10.7205/MILMED-D-10-00193.
3. National Center for Post-Traumatic Stress Disorder (US) aWRAMC. Iraq War Clinician Guide. 2nd ed. National Center for PTSD and the Department of Veterans Affairs. White River Junction, VT: National Center for Post-Traumatic Stress Disorder (2004).
4. Plumb TR, Peachey JT, Zelman DC. Sleep disturbance is common among service members and veterans of Operations Enduring Freedom and Iraqi Freedom. Psychol Serv (2014) 11(2):209-19. doi:10.1037/a0034958.
5. Mysliwiec V, Gill J, Lee H, Baxter T, Pierce R, Barr TL, et al. Sleep disorders in US military personnel: a high rate of comorbid insomnia and obstructive sleep apnea. Chest (2013) 144(2):549-57. doi:10.1378/chest.13-0088.
6. Martin SA, Aikens JE, Chervin RD. Toward cost-effectiveness analysis in the diagnosis and treatment of insomnia. Sleep Med Rev (2004) 8(1):63-72. doi:10.1016/j.smrv.2003.08.001.
7. Stoller MK. Economic effects of insomnia. Clin Ther (1994) 16(5):873-97.
8. Mysliwiec V, McGraw L, Pierce R, Smith P, Trapp B, Roth BJ. Sleep disorders and associated medical comorbidities in active duty military personnel. Sleep (2013) 36(2):167-74. doi:10.5665/sleep.2364.
9. Gehrman P, Seelig AD, Jacobson IG, Boyko EJ, Hooper TI, Gackstetter GD, et al. Predeployment sleep duration and insomnia symptoms as risk factors for new-onset mental health disorders following military deployment. Sleep (2013) 36(7):1009-18. doi:10.5665/sleep.2798.
10. Koffel E, Polusny MA, Arbisi PA, Erbes CR. Pre-deployment daytime and nighttime sleep complaints as predictors of post-deployment PTSD and depression in National Guard troops. J Anxiety Disord (2013) 27(5):512-9. doi:10.1016/j.janxdis.2013.07.003.
11. Pigeon WR, Campbell CE, Possemato K, Ouimette P. Longitudinal relationships of insomnia, nightmares, and PTSD severity in recent combat veterans. J Psychosom Res (2013) 75(6):546-50. doi:10.1016/j.jpsychores.2013.09.004.
12. Cho HJ, Lavretsky H, Olmstead R, Levin MJ, Oxman MN, Irwin MR. Sleep disturbance and depression recurrence in community-dwelling older adults: a prospective study. Am J Psychiatry (2008) 165:1543-50. doi:10.1176/appi.ajp.2008.07121882.
13. Hoge CW, Castro CA, Messer SC, McGurk D, Cotting DI, Koffman RL. Combat duty in Iraq and Afghanistan, mental health problems and barriers to care. US Army Med Dep J (2008):7-17.
14. Fear NT, Seddon R, Jones N, Greenberg N, Wessely S. Does anonymity increase the reporting of mental health symptoms? BMC Public Health (2012) 12:797. doi:10.1186/1471-2458-12-797.
15. Luxton DD, Greenburg D, Ryan J, Niven A, Wheeler G, Mysliwiec V. Prevalence and impact of short sleep duration in redeployed OIF soldiers. Sleep (2011) 34(9):1189-95. doi:10.5665/SLEEP.1236.
16. Church D, Hawk C, Brooks AJ, Toukolehto O, Wren M, Dinter I, et al. Psychological trauma symptom improvement in veterans using emotional freedom techniques: a randomized controlled trial. J Nerv Ment Dis (2013) 201(2):153-60. doi:10.1097/NMD.0b013e31827f6351.
17. Lopresti AL, Drummond PD. Obesity and psychiatric disorders: commonalities in dysregulated biological pathways and their implications for treatment. Prog Neuropsychopharmacol Biol Psychiatry (2013) 45:92-9. doi:10.1016/j.pnpbp.2013.05.005.
18. Prather AA, Marsland AL, Hall M, Neumann SA, Muldoon MF, Manuck SB. Normative variation in self-reported sleep quality and sleep debt is associated with stimulated pro-inflammatory cytokine production. Biol Psychol (2009) 82(1):12-7. doi:10.1016/j.biopsycho.2009.04.008.
19. Chennaoui M, Sauvet F, Drogou C, Van Beers P, Langrume C, Guillard M, et al. Effect of one night of sleep loss on changes in tumor necrosis factor alpha (TNF-alpha) levels in healthy men. Cytokine (2011) 56(2):318-24. doi:10.1016/j.cyto.2011.06.002.
20. Axelsson J, Rehman JU, Akerstedt T, Ekman R, Miller GE, Hoglund CO, et al. Effects of sustained sleep restriction on mitogen-stimulated cytokines, chemokines and T helper 1/T helper 2 balance in humans. PLoS One (2013) 8(12):e82291. doi:10.1371/journal.pone.0082291.
21. Vgontzas AN, Zoumakis M, Papanicolaou DA, Bixler EO, Prolo P, Lin HM, et al. Chronic insomnia is associated with a shift of interleukin-6 and tumor necrosis factor secretion from nighttime to daytime. Metabolism (2002) 51(7):887-92. doi:10.1053/meta.2002.33357.
22. Gill JM, Saligan L, Woods S, Page G. PTSD is associated with an excess of inflammatory immune activities. Perspect Psychiatr Care (2009) 45(4):262-77. doi:10.1111/j.1744-6163.2009.00229.x.
23. Heinzelmann M, Lee H, Rak H, Livingston W, Barr T, Baxter T, et al. Sleep restoration is associated with reduced plasma C-reactive protein and depression symptoms in military personnel with sleep disturbance after deployment. Sleep Med (2014) 15(12):1565-70. doi:10.1016/j.sleep.2014.08.004.
24. Gill J, Lee H, Barr T, Baxter T, Heinzelmann M, Rak H, et al. Lower health related quality of life in U.S. military personnel is associated with service-related disorders and inflammation. Psychiatry Res (2014) 216(1):116-22. doi:10.1016/j.psychres.2014.01.046.
25. Heinzelmann M, Gill J. Epigenetic mechanisms shape the biological response to trauma and risk for PTSD: a critical review. Nurs Res Pract (2013) 2013:10. doi:10.1155/2013/417010.
26. Rollins B, Martin MV, Morgan L, Vawter MP. Analysis of whole genome biomarker expression in blood and brain. Am J Med Genet B Neuropsychiatr Genet (2010) 153B(4):919-36. doi:10.1002/ajmg.b.31062.
27. Kohane IS, Valtchinov VI. Quantifying the white blood cell transcriptome as an accessible window to the multiorgan transcriptome. Bioinformatics (2012) 28(4):538-45. doi:10.1093/bioinformatics/btr713.
28. Gouin JP, Connors J, Kiecolt-Glaser JK, Glaser R, Malarkey WB, Atkinson C, et al. Altered expression of circadian rhythm genes among individuals with a history of depression. J Affect Disord (2010) 126(1-2):161-6. doi:10.1016/j.jad.2010.04.002.
29. Uddin M, Galea S, Chang SC, Aiello AE, Wildman DE, de los Santos R, et al. Gene expression and methylation signatures of MAN2C1 are associated with PTSD. Dis Markers (2011) 30(2-3):111-21. doi:10.3233/DMA-2011-0750.
30. Buysse DJ, Reynolds CF III, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res (1989) 28(2):193-213. doi:10.1016/0165-1781(89)90047-4.
31. Trivedi MH, Rush AJ, Ibrahim HM, Carmody TJ, Biggs MM, Suppes T, et al. The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation. Psychol Med (2004) 34(1):73-82. doi:10.1017/S0033291703001107.
32. Weathers FW, Keane TM, Davidson JR. Clinician-administered PTSD scale: a review of the first ten years of research. Depress Anxiety (2001) 13(3):132-56. doi:10.1002/da.1029.
33. Wilkins KC, Lang AJ, Norman SB. Synthesis of the psychometric properties of the PTSD checklist (PCL) military, civilian, and specific versions. Depress Anxiety (2011) 28(7):596-606. doi:10.1002/da.20837.
34. Schroeder A, Mueller O, Stocker S, Salowsky R, Leiber M, Gassmann M, et al. The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Mol Biol (2006) 7:3. doi:10.1186/1471-2199-7-3.
35. Song Y, Zhou D, Guan Z, Wang X. Disturbance of serum interleukin-2 and interleukin-8 levels in posttraumatic and non-posttraumatic stress disorder earthquake survivors in Northern China. Neuroimmunomodulation (2007) 14(5):248-54. doi:10.1159/000112050.
36. öz-Arslan D, Rüscher W, Myrtek D, Ziemer M, Jin Y, Damaj BB, et al. IL-6 and IL-8 release is mediated via multiple signaling pathways after stimulating dendritic cells with lysophospholipids. J Leukoc Biol (2006) 80(2):287-97. doi:10.1189/jlb.1205751.
37. Gu Q, Shi Q, Yang H. The role of TLR and chemokine in wear particle-induced aseptic loosening. J Biomed Biotechnol (2012) 2012:596870. doi:10.1155/2012/596870.
38. Kablak-Ziembicka A, Przewlocki T, Stepien E, Pieniazek P, Rzeznik D, Sliwiak D, et al. Relationship between carotid intima-media thickness, cytokines, atherosclerosis extent and a two-year cardiovascular risk in patients with arteriosclerosis. Kardiol Pol (2011) 69(10):1024-31.
39. Sahin-Efe A, Katsikeris F, Mantzoros CS. Advances in adipokines. Metabolism (2012) 61(12):1659-65. doi:10.1016/j.metabol.2012.09.001.
40. Boscarino JA, Forsberg CW, Goldberg J. A twin study of the association between PTSD symptoms and rheumatoid arthritis. Psychosom Med (2010) 72(5):481-6. doi:10.1097/PSY.0b013e3181d9a80c.
41. Xue Y, Taub PR, Iqbal N, Fard A, Wentworth B, Redwine L, et al. Cardiac biomarkers, mortality, and post-traumatic stress disorder in military veterans. Am J Cardiol (2012) 109(8):1215-8. doi:10.1016/j.amjcard.2011.11.063.
42. Boyko EJ, Jacobson IG, Smith B, Ryan MA, Hooper TI, Amoroso PJ, et al. Risk of diabetes in U.S. military service members in relation to combat deployment and mental health. Diabetes Care (2010) 33(8):1771-7. doi:10.2337/dc10-0296.
43. Capuron L, Ravaud A, Gualde N, Bosmans E, Dantzer R, Maes M, et al. Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapy. Psychoneuroendocrinology (2001) 26(8):797-808. doi:10.1016/S0306-4530(01)00030-0.
44. Wium-Andersen MK, Orsted DD, Nielsen SF, Nordestgaard BG. Elevated C-reactive protein levels, psychological distress, and depression in 73, 131 individuals. JAMA Psychiatry (2013) 70(2):176-84. doi:10.1001/2013.jamapsychiatry.102.
45. Anderson G, Kubera M, Duda W, Lason W, Berk M, Maes M. Increased IL-6 trans-signaling in depression: focus on the tryptophan catabolite pathway, melatonin and neuroprogression. Pharmacol Rep (2013) 65(6):1647-54. doi:10.1016/S1734-1140(13)71526-3.
46. Lehto SM, Niskanen L, Herzig K-H, Tolmunen T, Huotari A, Viinamäki H, et al. Serum chemokine levels in major depressive disorder. Psychoneuroendocrinology (2010) 35(2):226-32. doi:10.1016/j.psyneuen.2009.06.007.
47. Lu S, Peng H, Wang L, Vasish S, Zhang Y, Gao W, et al. Elevated specific peripheral cytokines found in major depressive disorder patients with childhood trauma exposure: a cytokine antibody array analysis. Compr Psychiatry (2013) 54(7):953-61. doi:10.1016/j.comppsych.2013.03.026.
48. Wan Z, Ritchie I, Beaudoin MS, Castellani L, Chan CB, Wright DC. IL-6 indirectly modulates the induction of glyceroneogenic enzymes in adipose tissue during exercise. PLoS One (2012) 7(7):e41719. doi:10.1371/journal.pone.0041719.
49. Frier BC, Jacobs RL, Wright DC. Interactions between the consumption of a high-fat diet and fasting in the regulation of fatty acid oxidation enzyme gene expression: an evaluation of potential mechanisms. Am J Physiol Regul Integr Comp Physiol (2011) 300(2):R212-21. doi:10.1152/ajpregu.00367.2010.
50. Gilles C, Polette M, Mestdagt M, Nawrocki-Raby B, Ruggeri P, Birembaut P, et al. Transactivation of vimentin by beta-catenin in human breast cancer cells. Cancer Res (2003) 63(10):2658-64. doi:10.1371/journal.pone.0081584.
51. Chen ZS, Ling DJ, Zhang YD, Feng JX, Zhang XY, Shi TS. Octamer-binding protein 4 affects the cell biology and phenotypic transition of lung cancer cells involving beta-catenin/E-cadherin complex degradation. Mol Med Rep (2015) 11(3):1851-8. doi:10.3892/mmr.2014.2992.
52. Li K, Hu C, Mei C, Ren Z, Vera JC, Zhuang Z, et al. Sequential combination of decitabine and idarubicin synergistically enhances anti-leukemia effect followed by demethylating Wnt pathway inhibitor promoters and downregulating Wnt pathway nuclear target. J Transl Med (2014) 12:167. doi:10.1186/1479-5876-12-167.
53. Gould TD, Dow ER, O'Donnell KC, Chen G, Manji HK. Targeting signal transduction pathways in the treatment of mood disorders: recent insights into the relevance of the Wnt pathway. CNS Neurol Disord Drug Targets (2007) 6(3):193-204. doi:10.2174/187152707780619308.
54. Smith SM, Friedle SA, Watters JJ. Chronic intermittent hypoxia exerts CNS region-specific effects on rat microglial inflammatory and TLR4 gene expression. PLoS One (2013) 8(12):e81584. doi:10.1371/journal.pone.0081584.
55. Stavropoulos N, Young MW. Insomniac and Cullin-3 regulate sleep and wakefulness in Drosophila. Neuron (2011) 72(6):964-76. doi:10.1016/j.neuron.2011.12.003.
56. Stenfors CU, Magnusson Hanson L, Oxenstierna G, Theorell T, Nilsson LG. Psychosocial working conditions and cognitive complaints among Swedish employees. PLoS One (2013) 8(4):e60637. doi:10.1371/journal.pone.0060637.
57. Pfeiffenberger C, Allada R. Cul3 and the BTB adaptor insomniac are key regulators of sleep homeostasis and a dopamine arousal pathway in Drosophila. PLoS Genet (2012) 8(10):e1003003. doi:10.1371/journal.pgen.1003003.
58. Pfeffer M, Plenzig S, Gispert S, Wada K, Korf HW, Von Gall C. Disturbed sleep/wake rhythms and neuronal cell loss in lateral hypothalamus and retina of mice with a spontaneous deletion in the ubiquitin carboxyl-terminal hydrolase L1 gene. Neurobiol Aging (2012) 33(2):393-403. doi:10.1016/j.neurobiolaging.2010.02.019.
59. Wright KM, Britt TW, Bliese PD, Adler AB, Picchioni D, Moore D. Insomnia as predictor versus outcome of PTSD and depression among Iraq combat veterans. J Clin Psychol (2011) 67(12):1240-58. doi:10.1002/jclp.20845.
60. Eibner C, et al. The cost of post-deployment mental health and cognitive conditions. In: Tanielian T, Jaycox LH, editors. Invisible Wounds of War: Psychological and Cognitive Injuries, their Consequences and Services to Assist Recovery. Vol. 1-2 (2008).